Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Beauty Health (SKIN) EBIT (2020 - 2026)

SkinHealth Systems has reported EBIT over the past 6 years, most recently at $162000.0 for Q4 2025.

  • Quarterly EBIT rose 102.26% to $162000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$20.8 million through Dec 2025, up 69.31% year-over-year, with the annual reading at -$20.8 million for FY2025, 69.31% up from the prior year.
  • EBIT was $162000.0 for Q4 2025 at SkinHealth Systems, up from -$6.2 million in the prior quarter.
  • Over five years, EBIT peaked at $2.4 million in Q1 2021 and troughed at -$82.1 million in Q3 2023.
  • The 5-year median for EBIT is -$11.3 million (2021), against an average of -$14.3 million.
  • Year-over-year, EBIT crashed 1786.08% in 2023 and then skyrocketed 102.26% in 2025.
  • A 5-year view of EBIT shows it stood at -$10.5 million in 2021, then surged by 76.69% to -$2.4 million in 2022, then crashed by 650.0% to -$18.4 million in 2023, then surged by 61.02% to -$7.2 million in 2024, then skyrocketed by 102.26% to $162000.0 in 2025.
  • Per Business Quant, the three most recent readings for SKIN's EBIT are $162000.0 (Q4 2025), -$6.2 million (Q3 2025), and -$2.7 million (Q2 2025).